Rollins Inc <ROL.N>: Argus Research cuts to Hold from Buy
ROL•Related News
Advantage Solutions Reiterates Full-Year
ADV•
GlucoTrack prices $2 million registered direct offering at $0.75 per unit
GCTK•
ScanSource schedules fiscal 2026 Q4, full-year results release and earnings call
SCSC•
BioCryst Pharmaceuticals, - Cash, Cash Equivalents, Restricted Cash And Investments $354 Million At June 30, 2026
BCRX•
Beamr integrates NVIDIA Video Super Resolution into live sports, broadcast workflows
BMR•